Nitroxide radical-modified CuS nanoparticles for CT/MRI imaging-guided NIR-II laser responsive photothermal cancer therapy

被引:4
|
作者
Xia, Chengwan [1 ]
Xie, Diya [1 ]
Xiong, Lang [1 ]
Zhang, Qian [1 ]
Wang, Yang [1 ]
Wang, Zezheng [1 ]
Wang, Yuxin [1 ]
Li, Bin [1 ]
Zhang, Chao [1 ,2 ]
机构
[1] Nanjing Univ, Nanjing Stomatol Hosp, Med Sch, Nanjing 210093, Jiangsu, Peoples R China
[2] Nanjing Univ, Collaborat Innovat Ctr Chem Life Sci, Coll Engn & Appl Sci, Nanjing 210093, Jiangsu, Peoples R China
关键词
MICROENVIRONMENTAL REGULATION; COMPUTED-TOMOGRAPHY; GOLD NANOPARTICLES; GENE TRANSFECTION; CONTRAST AGENTS; DRUG-DELIVERY; CHEMOTHERAPY; GRAPHENE; OXIDE; STERILIZATION;
D O I
10.1039/c8ra04501a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Herein, we reported nitroxide radical-modified CuS nanoparticles (CuS-NO center dot NPs), and they exhibited a typical absorption peak at 1182 nm. Due to such a long wavelength absorbance, CuS-NO center dot NPs exhibited excellent therapeutic outcome and low damage to normal tissues. Besides, we simultaneously achieved CuS-NO center dot NPs for MRI and CT dual-modal imaging, which successfully provided a new strategy for imaging-guided tumor treatment, thus increasing potential clinical applications for cancer treatment.
引用
收藏
页码:27382 / 27389
页数:8
相关论文
共 50 条
  • [1] NIR-II Fluorescence Imaging-Guided Photothermal Therapy with Amphiphilic Polypeptide Nanoparticles Encapsulating Organic NIR-II Dye
    Cheng, Quan
    Li, Tuanwei
    Tian, Youliang
    Dang, Huiping
    Qian, Hongyun
    Teng, Changchang
    Xie, Kai
    Yan, Lifeng
    ACS APPLIED BIO MATERIALS, 2020, 3 (12) : 8953 - 8961
  • [2] A simple POM clusters for in vivo NIR-II photoacoustic imaging-guided NIR-II photothermal therapy
    Han, Yahong
    Qu, Botao
    Li, Juan
    Zhang, Xiaomin
    Peng, Xiaoyang
    Li, Weihua
    Zhang, Ruiping
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 209
  • [3] NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death
    Wang, Yukun
    Li, Wenjing
    Lin, Bi
    Yuan, Ying
    Ning, Pengbo
    Tao, Xiaofeng
    Lv, Ruichan
    BIOMATERIALS SCIENCE, 2023, 11 (15) : 5177 - 5185
  • [4] Semiconducting polymer nanoparticles for NIR-II fluorescence imaging-guided photothermal/thermodynamic combination therapy
    Wang, Wenqi
    Zhang, Xi
    Ni, Xiaoyue
    Zhou, Wen
    Xie, Chen
    Huang, Wei
    Fan, Quli
    BIOMATERIALS SCIENCE, 2022, 10 (03) : 846 - 853
  • [5] Conjugated Polymer Coupled with Nonconjugated Segments for NIR-II Fluorescence/NIR-II Photoacoustic Imaging-Guided NIR-II Photothermal Therapy
    Hu, Danni
    Du, Xinlong
    Qu, Fan
    Yang, Zelan
    Chen, Pengfei
    Shen, Qingming
    Miao, Han
    Sun, Pengfei
    Fan, Quli
    ACS APPLIED POLYMER MATERIALS, 2023, 5 (10) : 8712 - 8719
  • [6] Thiadiazoloquinoxaline-Based Semiconducting Polymer Nanoparticles for NIR-II Fluorescence Imaging-Guided Photothermal Therapy
    Gu, Xuxuan
    Liao, Keyue
    Lu, Xiaomei
    Huang, Wei
    Fan, Quli
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [7] An effective and specific cancer theranostic nanoplatform with NIR-II fluorescence imaging-guided photothermal/chemodynamic therapy
    Han, Tingxi
    Cui, Di
    Wu, Meng
    Sun, Qijun
    Chen, Yuxue
    Niu, Na
    Chen, Ligang
    MICROCHEMICAL JOURNAL, 2024, 206
  • [8] NIR-II Fluorescence Imaging-guided Photothermal Activated Pyroptosis For Precision Therapy Of Glioma
    Chen, Zhuang
    Luo, Yi
    Jia, Qian
    Yang, Zuo
    Liu, Zebing
    Cui, Can
    Qiao, Chaoqiang
    Yang, Peng
    Wang, Zhongliang
    CHEMBIOCHEM, 2025, 26 (04)
  • [9] A PEGylated conjugated-BODIPY oligomer for NIR-II imaging-guided photothermal therapy
    Wang, Yuan
    Shan, Tongtong
    Zheng, Jiahao
    Tian, Jia
    Zhang, Weian
    JOURNAL OF MATERIALS CHEMISTRY B, 2025,
  • [10] Multifunctional Nanotheranostic Agent for NIR-II Imaging-Guided Synergetic Photothermal/Photodynamic Therapy
    Li, Tuanwei
    Liu, Le
    Xu, Pengping
    Yuan, Pan
    Tian, Youliang
    Cheng, Quan
    Yan, Lifeng
    ADVANCED THERAPEUTICS, 2021, 4 (03)